OYE has repurposed and reformulated a injectable drug product that accelerates emergence from anesthesia roughly 50% faster than the current standard of care. The downstream impact of the intervention ...

SEngine Precision Medicine Inc. is a precision oncology company revolutionizing cancer diagnostics and therapies by pre-testing drugs on patient-derived organoids grown ex-vivo utilizing patient ...

Thank you for downloading the BIO Membership Brochure! You can access the brochure below, and we will also send you a copy via email to keep for your records and pass along to your colleagues. If you ...